Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rucaparib switch maintenance after platinum chemotherapy in platinum-sensitive ovarian, primary peritoneal, or fallopian tube cancer
2013-000518-39Phase 3Unknown
- Sponsor
- Clovis Oncology
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ovarian cancer, primary peritoneal cancer (PPC) and fallopian tube cancer (PFTC) comparing Rucaparib maintenance with Placebo maintenance (2 arms). Primary endpoint: Investigator-assessed progression-free survival. Status: unknown.
02
Drugs
rucaparib
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on 2013-000518-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000518-39.